Reuter G

ORCID: 0000-0002-7484-3110 · 1 paper in corpus

guideline 2025

Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies

Brain & spine ·doi:10.1016/j.bas.2024.104154

INTRODUCTION: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many ca…